Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities ...

U.S. approval of an expanded indication for transcatheter aortic valve replacement in patients without symptoms is among the ...

The global TAVR embolic protection market is experiencing steady growth, with revenue estimated to increase from approximately $124 million in 2023 to around $403 million by 2032. This growth, driven ...

Anteris Technologies today announced the launch of its initial public offering in the U.S. to advance the development of its ...

The Myval THV series, known for its innovative contributions to transcatheter aortic valve replacement (TAVR) procedures, ...

US-based Protaryx Medical has completed a first-in-human trial of its transseptal puncture (TSP) device. The company’s trial enrolled five patients, with the TSP procedure carried out using its device ...

Medtronic has reported new clinical data from the study of its Evolut transcatheter aortic valve replacement (TAVR) system, ...

Advancements in medical technology have made it possible to replace heart valves using the TAVI (Transcatheter Aortic Valve ...

The global structural heart devices market is witnessing remarkable growth, driven by factors such as the rising prevalence of structural heart diseases, expanding indications for transcatheter ...

NEW YORK, NY / ACCESSWIRE / December 8, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to ...

On Wednesday, during its annual investor conference, Edwards Lifesciences Corporation (NYSE:EW) detailed its strategy for ...